Generics

Sandoz looks to market generic Vyvanse
May 20, 2011
Sandoz is looking to market a generic version of a Shire drug for treating...
more
Medco: Cancer drugs to see huge rise by 2013
May 18, 2011
Cancer drugs are expected to see sharp increases in spending and use by...
more
IMS Health: Global spending on medicines to reach nearly $1.1 trillion by 2015
May 18, 2011
Global spending on medicines will reach nearly $1.1 trillion by 2015,...
more
Court in France wants Mylan to pay Ipsen $24 million
May 17, 2011
A court in France has ordered generic drug maker Mylan to pay French drug...
more
Perrigo receives final approval for generic Zantac 150
May 17, 2011
Perrigo on Monday announced that it has received final approval from the...
more
Mylan's generic Xibrom ophthalmic solution enters market
May 16, 2011
Mylan has launched a generic drug for treating post-operative inflammation...
more
Teva to acquire Taiyo
May 16, 2011
Generic drug maker Teva Pharmaceutical Industries will acquire a privately...
more

PATIENT VIEWS

Pharmacy customers drawn to on-site beauty services
As many as 58% of consumers are likely to purchase beauty services — such as...

MORE PATIENT VIEWS >

VIDEO

HHS Secretary Sebelius speaks at CVS/pharmacy, MinuteClinic about new Medicare benefits
CVS Caremark and the Centers for Medicare and Medicaid Services have teamed up...

SPECIAL REPORT

Generic Drug Report 2013
The generic drug tidal wave became a tsunami in 2012, with some of the world's...

PHARMACIST CE

March/April 2013
Advancing the management of hepatitis C

Treatment options for patients with irritable bowel syndrome

PHARMACY AFFAIRS

Walgreens omnichannel evolution in pharmacy
DSN recently sat down with Suzanne Hansen, Walgreens group VP pharmacy...

COLLABORATIVE CARE E-NEWSLETTER

Get the latest news in retail health with the DSN Collaborative Care E-Newsletter. Product news, clinical updates, patient health information — everything you need to stay on top of your industry.

Sign up for free here!

© 2013 Drug Store News. All Rights Reserved.